Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 39 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
u.s. department of veterans affairs
Grant: I01 BX003916, P50026787 (NIH/NIDCR)
National Cancer Institute
Grant: U01CA233102
National Cancer Institute
Grant: P30 CA014520
NCI NIH HHS
Grant: U01 CA224166
BLRD VA
Grant: I01 BX003916
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5U01CA233102-04
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
Barbara A. Suran Comparative Research Endowment
FWCI
2.61
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals